Page last updated: 2024-08-23

dobutamine and 8-bromoadenosine-3',5'-cyclic monophosphorothioate

dobutamine has been researched along with 8-bromoadenosine-3',5'-cyclic monophosphorothioate in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Anwyl, R; Rowan, MJ; Wang, QW	1

Other Studies

1 other study(ies) available for dobutamine and 8-bromoadenosine-3',5'-cyclic monophosphorothioate

Article	Year
Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway. Neurobiology of aging, 2009, Volume: 30, Issue:10 Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Adrenergic Agents; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Amyloid beta-Peptides; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dentate Gyrus; Dobutamine; Enzyme Inhibitors; In Vitro Techniques; Long-Term Potentiation; Male; Propanolamines; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Signal Transduction; Terbutaline; Thionucleotides	2009

Article

Year

Inhibition of LTP by beta-amyloid is prevented by activation of beta2 adrenoceptors and stimulation of the cAMP/PKA signalling pathway.

Neurobiology of aging, 2009, Volume: 30, Issue:10

Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenylyl Cyclases; Adrenergic Agents; Adrenergic beta-1 Receptor Agonists; Adrenergic beta-2 Receptor Agonists; Adrenergic beta-2 Receptor Antagonists; Amyloid beta-Peptides; Animals; Colforsin; Cyclic AMP; Cyclic AMP-Dependent Protein Kinases; Dentate Gyrus; Dobutamine; Enzyme Inhibitors; In Vitro Techniques; Long-Term Potentiation; Male; Propanolamines; Rats; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Signal Transduction; Terbutaline; Thionucleotides

2009